Caroline Drinkwater is the Children’s Cancer Foundation Biobank Specialist for the Hudson Monash Paediatric Precision Medicine Program.
In the collaborative Hudson Monash Paediatric Precision Medicine Program, scientists at Hudson Institute will establish a living biobank of paediatric brain tumours and solid cancers – including living organoids or lab-grown ‘mini-tumours’ – to trial and develop targeted treatments and improve clinical outcomes, survival rates and quality of life (limiting side-effects) for childhood cancer patients. As the Biobank Specialist for the program, Caroline oversees the collection and processing of patient samples to be provided directly to researchers at the Hudson Institute. In addition, she supports the maintenance of the Monash Children’s Cancer Biobank.
Caroline brings technical and operational biobanking knowledge, to establish a living biobank platform at the Hudson Institute. Additionally, Caroline represents the Hudson Institute as a Site Coordinator for the new collaborative membership with the Children’s Brain Tumor Tissue Consortium (CBTTC) in Philadelphia, US. She is also an active member for the Australian and New Zealand Childhood Haematology and Oncology (ANZCHOG) Biobanking Network, representing the Monash Children’s Cancer Biobank.